|
|
||||||||
First Department of Medicine, Division of Pathophysiology, University of Mainz, Mainz, Germany
IL-6 is a multifactorial cytokine mediating acute inflammatory responses in the liver. When IL-6 binds to a specific receptor (IL-6R), the IL-6/IL-6R complex associates with the signal transducer gp130, initiating intracellular signaling. A soluble form of the IL-6R (sIL-6R) renders target cells sensitive to IL-6 that do not express the IL-6R on their surfaces. A designer cytokine, termed Hyper-IL-6, consisting of IL-6 covalently linked to the sIL-6R was fully active on gp130-expressing cells at 100- to 1000-fold lower concentrations than unlinked IL-6 and IL-6R. Mice were injected i.p. with Hyper-IL-6 or IL-6. Upon injection of Hyper-IL-6 into mice, the acute phase response, as measured by haptoglobin mRNA expression in the liver, was markedly increased and lasted significantly longer compared with that in mice injected with a 10-fold higher dose of IL-6 alone. On human hepatoma cells, Hyper-IL-6 caused similar effects, indicating that the longer lasting response to the fusion protein could not only be explained by the longer plasma half-life of the fusion protein. Experiments using iodinated IL-6 and Hyper-IL-6 revealed that Hyper-IL-6 bound with high affinity to gp130 and was less efficiently internalized. This effect might explain the longer lasting activity of this protein on cells. The highly active IL-6/sIL-6R designer protein might be of significant clinical importance for the stimulation of cells that are more responsive to the IL-6/sIL-6R complex than to IL-6 alone. Such cells include hemopoietic progenitor cells and hepatocytes.
This article has been cited by other articles:
![]() |
S. Tenhumberg, G. H. Waetzig, A. Chalaris, B. Rabe, D. Seegert, J. Scheller, S. Rose-John, and J. Grotzinger Structure-guided Optimization of the Interleukin-6 Trans-signaling Antagonist sgp130 J. Biol. Chem., October 3, 2008; 283(40): 27200 - 27207. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chattopadhyay, E. Tracy, P. Liang, O. Robledo, S. Rose-John, and H. Baumann Interleukin-31 and Oncostatin-M Mediate Distinct Signaling Reactions and Response Patterns in Lung Epithelial Cells J. Biol. Chem., February 2, 2007; 282(5): 3014 - 3026. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Brandl, T. Gluck, P. Hartmann, B. Salzberger, and W. Falk A designed TLR4/MD-2 complex to capture LPS Innate Immunity, August 1, 2005; 11(4): 197 - 206. [Abstract] [PDF] |
||||
![]() |
S. J. Curnow, D. Scheel-Toellner, W. Jenkinson, K. Raza, O. M. Durrani, J. M. Faint, S. Rauz, K. Wloka, D. Pilling, S. Rose-John, et al. Inhibition of T Cell Apoptosis in the Aqueous Humor of Patients with Uveitis by IL-6/Soluble IL-6 Receptor trans-Signaling J. Immunol., October 15, 2004; 173(8): 5290 - 5297. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Brabant, H. Nave, B. Mayr, M. Behrend, V. van Harmelen, and P. Arner Secretion of Free and Protein-Bound Leptin from Subcutaneous Adipose Tissue of Lean and Obese Women J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3966 - 3970. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Audet, C. L. Miller, S. Rose-John, J. M. Piret, and C. J. Eaves Distinct role of gp130 activation in promoting self-renewal divisions by mitogenically stimulated murine hematopoietic stem cells PNAS, February 13, 2001; 98(4): 1757 - 1762. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. GALUN, E. ZEIRA, O. PAPPO, M. PETERS, and S. ROSE-JOHN Liver regeneration induced by a designer human IL-6/sIL-6R fusion protein reverses severe hepatocellular injury FASEB J, October 1, 2000; 14(13): 1979 - 1987. [Abstract] [Full Text] |
||||
![]() |
P. W. Zandstra, D. A. Lauffenburger, and C. J. Eaves A ligand-receptor signaling threshold model of stem cell differentiation control: a biologically conserved mechanism applicable to hematopoiesis Blood, August 15, 2000; 96(4): 1215 - 1222. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ezure, T. Sakamoto, H. Tsuji, J. G. Lunz III, N. Murase, J. J. Fung, and A. J. Demetris The Development and Compensation of Biliary Cirrhosis in Interleukin-6-Deficient Mice Am. J. Pathol., May 1, 2000; 156(5): 1627 - 1639. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |